2023

1. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

   Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193